Nippon India Pharma Fund-Growth Plan-Growth Option - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Status: Open
Portfolio Overview
As of April 30, 2026
Asset Allocation
Equity: 98.68%Others: 1.32%
Market Cap
Large Cap: 32.97%Mid Cap: 37.85%Small Cap: 26.90%Others: 0.96%
Number of stocks
35
Top 10 Holdings
59.53% of portfolio
Market Cap of Equity
Large Cap
32.97%
Mid Cap
37.85%
Small Cap
26.90%
Others
0.96%
Companies Allocation of Equity
Sun Pharmaceuticals Industries Ltd13.85%
Lupin Ltd7.95%
Dr Reddy's Laboratories Ltd7.04%
Divi's Laboratories Ltd6.61%
Cipla Ltd5.47%
Apollo Hospitals Enterprise Ltd5.01%
Medplus Health Services Ltd3.78%
Vijaya Diagnostic Centre Ltd3.36%
Sai Life Sciences Ltd3.27%
Ajanta Pharma Ltd3.19%
Sector Allocation of Equity
Healthcare98.68%
SIP Amount
Monthly SIP Date
Nippon India Pharma Fund-Growth Plan-Growth Option


Is This Mutual Fund Right for You?
+10k investors used our Suitability Test to get better returns
Fund Suitability Test
Let's Get Started.
Frequently Asked Questions
Everything You Need To Know To Get Started With Confidence
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.


